menu
    • menu

    Company profile for Epicrispr Biotechnologies

    NEW Drugs in Dev.: 1
    Evonik

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    End-to-end drug development, specializing in high-potency softgels and liquids, providing global partners with a competitive advantage.

    Virtual Booth

    Contact Supplier

    Kewpie is your partner for Sodium Hyaluronate & Hyaluronic Acid// CEP, USDMF, KDMF & JDMF registered.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    ​Epicrispr Biotechnologies is pioneering genetic medicine by developing therapies that dynamically control gene expression to treat complex diseases. Leveraging the power of the epigenome, the system regulating gene activity in mammalian cells. Epicrispr has created the Gene Expression Modulation System (GEMS) platform. This mix and match toolbox of epigenomic modulators enables the customization of therapies for specific di...
    ​Epicrispr Biotechnologies is pioneering genetic medicine by developing therapies that dynamically control gene expression to treat complex diseases. Leveraging the power of the epigenome, the system regulating gene activity in mammalian cells. Epicrispr has created the Gene Expression Modulation System (GEMS) platform. This mix and match toolbox of epigenomic modulators enables the customization of therapies for specific disease indications.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Epicrispr BiotechnologiesUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    7000 Shoreline Court, Suite 100 South San Francisco, CA 94080
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://epicrispr.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/epicrispr-biotechnologies/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Epicrispr Biotech To Present At J.P. Morgan Healthcare Conference
    Epicrispr Biotech To Present At J.P. Morgan Healthcare Conference

    08 Dec 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-12-08/epicrispr-biotechnologies-to-present-at-44th-annual-jp-morgan-healthcare-conference

    PHARMIWEB
    08 Dec 2025
    Share Share
    Epicrispr Begins Human Trial of EPI-321 for Muscular Dystrophy
    Epicrispr Begins Human Trial of EPI-321 for Muscular Dystrophy

    05 Aug 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250805959888/en/Epicrispr-Biotechnologies-Doses-First-Patient-in-First-in-Human-Clinical-Trial-of-EPI-321-for-Facioscapulohumeral-Muscular-Dystrophy

    BUSINESSWIRE
    05 Aug 2025
    Share Share
    Epicrispr Named Finalist in XPRIZE Healthspan Prize
    Epicrispr Named Finalist in XPRIZE Healthspan Prize

    12 May 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250512803482/en/Epicrispr-Biotechnologies-Named-Finalist-in-XPRIZE-Healthspan-Competition-FSHD-Bonus-Prize

    BUSINESSWIRE
    12 May 2025
    Share Share
    Epicrispr Biotechnologies Announces Five Presentations at ASGCT 2025
    Epicrispr Biotechnologies Announces Five Presentations at ASGCT 2025

    05 May 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250505956612/en/Epicrispr-Biotechnologies-Announces-Five-Presentations-Highlighting-Advances-in-Epigenetic-Modulation-and-AAV-Manufacturing-at-ASGCT-2025-Annual-Meeting

    BUSINESSWIRE
    05 May 2025
    Share Share
    Epicrispr Biotechnologies partners Springbok Analytics
    Epicrispr Biotechnologies partners Springbok Analytics

    23 Apr 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250423098005/en/Epicrispr-Biotechnologies-Partners-with-Springbok-Analytics-to-Integrate-AI-Muscle-Analysis-in-First-in-Human-FSHD-Study

    BUSINESSWIRE
    23 Apr 2025
    Share Share
    Epicrispr Biotech: FDA Clearance of IND Application for EPI-321
    Epicrispr Biotech: FDA Clearance of IND Application for EPI-321

    03 Apr 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250403888509/en/Epicrispr-Biotechnologies-Announces-FDA-Clearance-of-IND-Application-for-EPI-321-A-First-in-Class-Epigenetic-Therapy-for-FSHD

    BUSINESSWIRE
    03 Apr 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search